When Is it Safe To Discontinue Isolation?

Similar documents
Solid Organ Transplantation

Massachusetts Department of Developmental Services MRSA, VRE, and C. Diff Management Protocol

Lab ID Events MRSA Bloodstream Infection and C. difficile

C-Difficile Infection Control and Prevention Strategies

2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey

Clostridium difficile Infection (CDI) Gail Bennett, RN, MSN, CIC

Introduction to Infection Control

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection

Chapter 5. INFECTION CONTROL IN THE HEALTHCARE SETTING

ORTHOPAEDIC INFECTION PREVENTION AND CONTROL: AN EMERGING NEW PARADIGM

North Carolina Statewide Program for Infection Control and Prevention (SPICE) Objectives. Healthcare-Associated Infections: Impact

Recommendations for the Prevention and Control of Influenza in Nursing Homes Virginia Department of Health

Isolation Guidelines. VCU Health System Department of Epidemiology

Illinois Long Term Care Facilities and Assisted Living Facilities

Recommendations for Metrics for Multidrug-Resistant Organisms in Healthcare Settings: SHEA/HICPAC Position Paper

Norovirus Outbreak Among Residents of an Assisted Living Facility, Houston County, Alabama 2010 (AL1003NRV 35a)

Policy for Screening Patients for MRSA Colonisation

METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) COMMUNITY ACQUIRED vs. HEALTHCARE ASSOCIATED

Management of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings

Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis

Management of Norovirus Infection Outbreaks in Hospitals and Nursing Homes Noroviruses are a group of viruses that cause acute gastroenteritis in

NURSING SKILLS FAIR GAME QUESTIONS

Hialeah Nursing and Rehabilitation Center Combines Technology and Best Practices to Improve Infection Control Specific to C.diff

EAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY. Methicillin-resistant Staph aureus: Management in the Outpatient Setting

HSE Health Protection Surveillance Centre. Sample Root Cause Analysis Tool of Hospital-acquired Clostridium difficile Infection

Pre-operative M.R.S.A. Screening Information for Patients

Methicillin Resistant Staphylococcus aureus (MRSA) in Tasmanian Rural Hospitals and Non Acute Health Settings

Infection Prevention

Management of Communicable Diseases In a School Setting

Educational Module for Nursing Assistants in Long-term Care Facilities: Antibiotic Use and Antibiotic Resistance

VARICELLA ZOSTER (VZ) VIRUS, CHICKENPOX & SHINGLES GUIDANCE

4. Infection control measures

Prevention and control of infection in care homes. Summary for staff

MRSA, Hand Hygiene and Contact Precautions

Risk Assessment for all Healthcare workers. Gayle Lohr & Joanne Baines Leaders, Infection Prevention & Control

State of Kuwait Ministry of Health Infection Control Directorate. Guidelines for Prevention of Surgical Site Infection (SSI)

Infection Control for Non Clinical Healthcare Workers

PERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL

Approaches to Infection Control

Infection Prevention and Control Program Risk Assessment 2011

growing problem By: Jena Cummins, Doctor of Pharmacy Candidate

SKILLS FAIR GAME QUESTIONS FOR LICENSED NURSES

BODY SUBSTANCE ISOLATION (BSI): THE STANDARD OF CARE

Laboratory confirmation requires isolation of Bordetella pertussis or detection of B. pertussis nucleic acid, preferably from a nasopharyngeal swab.

Infection Control Program Risk Assessment 2008

Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs)

Methicillin resistant staphylococcus aureus (MRSA)

Policy Clinical Guideline Management of Patients with Methicillin-resistant

University of St. Francis

INFECTION CONTROL PRECAUTIONS

PENNSYLVANIA DEPARTMENT OF HEALTH 2015 PAHAN ADV Pertussis in Centre County

SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus

Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4

Ebola: Teaching Points for Nurse Educators

INFECTION CONTROL MANUAL

Objective 1A: Increase the adoption and effective use of health IT products, systems, and services

Gail Bennett, RN, MSN, CIC

PCORnet Use Cases. Cluster randomized trial: Routine decolonization of non-icu medical surgical patients to prevent healthcare associated infections

APIC Practice Guidance Committee: Implementation Insights Prevention & Control of Pertussis

Baseline assessment checklist for the AICG recommendations

June 10, Dear Mr. Slavitt:

Haemophilus Influenzae (meningitis and invasive

California Antimicrobial Stewardship Program Initiative & Clostridium difficile Infection (CDI) Project

Tuberculosis Exposure Control Plan for Low Risk Dental Offices

TITLE: CLOSTRIDIUM DIFFICILE INFECTION (CDI): GUIDELINES FOR THE MANAGEMENT OF ADULT PATIENTS

Infectious Disease Issues Associated with Hurricane Katrina (HK) Joe Posid Centers for Disease Control and Prevention

Welcome and Instructions

Implementing the Long-Term Care UTI Toolkit Wisconsin Coalition on HealthCare Association Infection in Long Term Care

ECDC INTERIM GUIDANCE

Black Hills Healthcare System

NASAL COLONIZATION BY MICROORGANISMS IN NURSING PROFESSIONALS IN UNITS SPECIALIZING IN HIV/AIDS

Microbiology Specimen Collection Instructions. Alphabetical List of Microbiology Tests

Infection Prevention WEBINAR SERIES

Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities *

Bloodborne Pathogens, Infection Control

Living healthy with MRSA

Yale New Haven Health System Center for Healthcare Solutions

Addressing the challenge of healthcare associated infections (HCAIs) in Europe

Influenza Surveillance Weekly Report CDC MMWR Week 16: Apr 17 to 23, 2016

Why Do Some Antibiotics Fail?

Answers to Frequently Asked Questions on Reporting in NHSN

Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital

The Legal Cost of Getting Infection Prevention and Control Wrong

Hand Hygiene and Infection Control

Report by the Comptroller and Auditor General. The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England

Recommendations for the Prevention and Control of Influenza in Nursing Homes Virginia Department of Health

Catheter-Associated Urinary Tract Infection (CAUTI) Prevention. Basics of Infection Prevention 2 Day Mini-Course 2013

Basic Presentation HIV/AIDS. For Use by Students, Teachers and the Public Seeking Basic Information About HIV/AIDS

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

PRIORITY RESEARCH TOPICS

COMMONWEALTH of VIRGINIA Department of Health

Infection Prevention Program in Ambulatory Surgical Facilities

A guide for people with genital herpes

4.06. Infection Prevention and Control at Long-term-care Homes. Chapter 4 Section. Background. Follow-up on VFM Section 3.06, 2009 Annual Report

b. Povidone Iodine 5% Swabsticks, Single Pack (4 packs) c. Clean gloves

PREVENTING THE SPREAD OF CONTAGIOUS ILLNESS

A Safe Patient. Commonwealth Nurses Federation. Jill ILIFFE Executive Secretary. Commonwealth Nurses Federation

GUIDELINES FOR THE MANAGEMENT OF PVL ASSOCIATED STAPHYLOCOCCUS AUREUS INFECTIONS IN THE HOSPITAL ENVIRONMENT

Ambulance Service Patient Care and Transportation Standards

Transcription:

When Is it Safe To Discontinue Isolation? Vickie Brown, RN, MPH, CIC Associate Director Hospital Epidemiology UNC Hospitals Chapel Hill, North Carolina Isolated journalists peer thru a window of a SARS isolation ward-beijing Photo: AFP/Frederic Brown www.smh.com.au/ April 19, 2003

Acknowledgements David J. Weber, MD, MPH Medical Director Hospital Epidemiology Associate Chief of Staff UNC Hospitals Chapel Hill, NC

Major Isolation Categories Airborne for those diseases known to be transmitted via the airborne route TB, varicella Droplet for those diseases known to be transmitted via respiratory droplets Invasive meningiococcal disease, pertussis, influenza Contact for those diseases known to be transmitted via direct contact or indirectly via a contaminated object CDAD, VRE, MRSA

Questions To Ask? Is the Pathogen Normal Flora? Is the pathogen in a secretion/body substance such as respiratory secretions or stool? If present, is it sufficient dose/route to lead to transmission?

More Considerations Is the period of communicability related to: Time? (e.g., Influenza, parvovirus) Symptom resolution? (e.g., CDAD, varicella, measles) Lab-based? (e.g., MRSA, VRE)

References Guidelines for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007 Centers for Disease Control and Prevention Control of Communicable Diseases Manuel, 2004 American Public Health Association Red Book, 2006 American Academy of Pediatrics

Influenza Viral shedding in respiratory secretions is usually limited to 5 7 days CDC 2007 Isolation Guidelines: Droplet Precautions for 5 days after onset of illness

Viral Shedding of Influenza Meta-analysis of 56 studies with 1,280 healthy participants challenged with an influenza virus (1091) Type A, (189) Type B Sharp increase in shedding between 0.5 and 1 day after challenge Consistently peaked on day 2 Duration of viral shedding (375 participants) was 4.80 days (95% confidence interval: 4.31,5.29) Carrat, F. Am J Epidemiol 2008; 176:775-785

Influenza B and Prolonged Shedding 214 patients underwent viral isolation before, and between, days 4 and 6 after an initial dose of oseltamivir Re-isolation rates of influenza B was significantly higher than for influenza A across all age groups (p-value <0.001) Re-isolation rates for both types of influenza were higher for children 0-15 years Kawai, N. J Infection 2007;55:267-272

Influenza A in Hospitalized Patients And Prolonged Viral Shedding Leeha, S. Infect Control Hosp Epidemiol. 2007; 28: 1071-1076

Recommendation for Discontinuing Isolation CDC 2007 Isolation Guidelines: 5 days after onset of symptoms Immunocompetent population: 5 days Hospitalized population with patients at risk of pneumonia ( e.g., chronic lung diseases, immunosuppressed, neonates and elderly): Adults 7 to 10 days Children 10 days

Norovirus Viral shedding in stool is mostly limited to symptomatic period CDC 2007 Isolation Guidelines: duration of illness Prolonged shedding can occur especially in immunocompromised

Prolonged Shedding of Norovirus Sample of 10 elderly patients ( age 79-94 years), the median excretion of norovirus was 8.6 days (range 2-15 days) 1 Sample of 26 children (age 3 mo-3 years, the median excretion of norovirus was 16 days with a range of 5-47 days. For children <1 year (6/8) norovirus was detected more than 2 weeks after onset 2 1 Goller, JL. J Hosp Infection 2004; 58:286-291 2 Murato, T. Ped Infect Dis J 2007; 26:46-49

Recommendation for Discontinuing Isolation CDC 2007 Isolation Guidelines: Contact Isolation needed for duration of illness Generally interpreted as isolation can be stopped once diarrhea has resolved. Outbreak that is not controlled by above recommendation and appropriate surface decontamination: Consider prolonging isolation for up to 2 weeks especially in elderly and young children

C. difficile Occasionally normal flora, found in < 3% of healthy adults Once diarrhea stopped, C. difficile may still be present in stool but the amount excreted in stool and the amount of environmental contamination is reduced Assays may remain positive

Clostridium difficile Skin Contamination A. Frequency of C. Difficile contamination of skin sites of 27 patients. B. Frequency of acquisition on sterile gloves after contact with skin sites of a subset of 10 patients. C. Typical illustration of acquisition of C. Difficile on sterile gloves after contact with groin. Bobulsky, GS, CID. 2008; 46:447-50

Persistence of Skin Contamination Kaplan-Meier estimation of time from resolution of diarrhea (day 0) to negative results of culture specimens of abdomen and/or chest skin of patients with C. difficile associated disease. Bobulsky, GS, CID; 2008; 46: 447-50

Recommendation for Discontinuing Isolation CDC 2007 Isolation Guidelines: Contact Isolation needed for duration of illness Generally interpreted as isolation can be stopped once diarrhea has resolved. Outbreak that is not controlled by above recommendation along with appropriate surface decontamination: Consider prolonging isolation for 7-10 days after diarrhea resolved

Multi-drug Resistant Organisms (MDROs) Significant pathogens for hospitalized populations: Methicillin-resistant S. aureus (MRSA) Vancomycin-resistant enterococcus (VRE) MDR Gram-negative: Acinetobacter sp., pseudomonas aeruginosa MDR defined as susceptible to <2 classes of antibiotics

Management of Multidrugresistant Organisms in Healthcare Settings, 2006 Background information: In general, it seems reasonable to discontinue Contact Precautions when three or more surveillance cultures for the targeted MDRO are repeatedly negative over the course of a week or two in a patient who has not received antimicrobial therapy for several weeks, especially in the absence of a draining wound, profuse respiratory secretions, or evidence implicating the specific patient in ongoing transmission of the MDRO within the facility. No recommendation for when to D/C Contact Precautions unresolved issue. Guidelines do recommend the use of a computer system to record long term isolation indicators for patients colonized with MRSA, VRE, VISA, or VRSA so that on return to the hospital an alert will be provided of the need for isolation (1B)

2003 SHEA Guidelines for MRSA and VRE No specific recommendation for when isolation can be discontinued

MRSA S. aureus, including those strains that are methicillin and oxacillin resistant, frequently colonizes humans and is considered normal flora Found in respiratory secretions, skin, vaginal secretions and stool Colonization lasts for months to years Capable of being transmitted in the carrier state

MRSA Multiple studies have shown that persons can stay colonized with MRSA for long periods of time and that carriage can be intermittent Current control measures include active surveillance cultures for early identification and isolation Discontinuing isolation too soon may increase the risk of transmission within a healthcare facility

MRSA: Duration of Carriage Study conducted in the Netherlands involved 135 patients positive for MRSA upon discharge from the hospital Patients were assessed every 6 months for carriage and MRSA risk factors At 6 months: 121 patients assessed, 60% (72) remained positive At 1 year: 99 patients assessed, 22% (22 patients) remained positive At 2 years: 47 patients assessed, 13% (6) remained positive Vriens, MR. Infect Control Hosp Epidemiol 2005; 26: 629-633

Virens Study Con t. Eradication therapy* provided to 31 patients without risk factors for MRSA carriage Eradication treatment effective for 95% of the patients within 1 year * mupirocin nasal ointment combined with chlorhexidine body and hair washing for 5 days, GI carriage: antibiotic therapy provided

MRSA: Duration of Carriage Prospective 10 month study involving 78 patients admitted to a 1200 bed French hospital who were known to have MRSA from a previous admission All were readmitted >3 mo after the end of the previous stay 40% remained positive at time of readmission The median time to a negative MRSA screen was 8.5 mo Scanvic A. CID 2001; 32: 1393-98

Scanvic Study Con t. Kaplan-Meier estimates of time until results of screenings for MRSA became negative for readmitted patients (%)

Recommendation for Discontinuing Isolation Off antibiotics for a minimum of 1 week, extend to 3 weeks if on dialysis 3 negative cultures (or PCR) from the original site and from the nares Obtain 1 week apart Decolonization therapy does not alter above

VRE Enterococcus is normal flora found in the GI tract, vagina, and oral cavity Found in large numbers in human stool Colonization with vancomycin resistant strains can be prolonged years in some cases

VRE and Length of Colonization 116 patients hospitalized at the University of Virginia Hospital who were identified with VRE F/u cultures obtained on outpatient visits or during hospital stay First f/u culture was collected a mean of 125 days after the initial positive isolate Byers KR Infect Control Hosp Epidemiol 2002; 23: 207-211

Byers Con t After 1 st f/u culture: 64% negative After 1 st negative f/u culture: 92% negative After 2 negative f/u cultures: 95% remained culture negative 22 patients remained persistently colonized for >100 days, including one patient who remained colonized 709 days after the initial isolation

Recurrence of VRE 16 patients who had cleared VRE colonization 3/16 received no antibiotics during study period and remained VRE negative (f/u cultures obtained an average of 5 mo since initial 3 negatives) 13/16 patients received antibiotics during the study period 8/13 (62%) developed recurrent VRE PFGE suggested that both relapse and acquisition of a new strain occurred Donskey, MD Infect Control Hosp Epidemiol 2002; 23: 436-440

Recommendation for Discontinuing Isolation 3 negative stool cultures collected off antibiotics and collected 1 week apart is sufficient Consider re-screening patients who receive anti-anaerobic antibiotics, esp. if VRE colonization/infection rates are high

Acinetobacter species Widely distributed in the environment and can colonize the skin of healthy individuals Studies of healthy military recruits found 17% (17/102) had skin colonization; however, when their isolates were compared to clinical isolates from injured soldiers, none showed genetic similarities* Swab specimens from the nares of 293 healthy soldiers undergoing military training in Texas found no acinetobacter colonization.** *Griffith, M. Infect Control Hosp Epidemiol 2006; 27:659-661 **Griffith, M. Infect Control Hosp Epidemiol 2006; 27:787-788

Surveillance Cultures Twenty two patients with recent (<10 days) acinetobacter isolates were considered carriers Six body sites sampled with 12 patients having at least 1 positive surveillance culture Overall sensitivity of 55% Marchaim D. J Clin Micro 2007; 45: 1551-1555

Sensitivities of Surveillance Cultures Culture site No. Patients Sampled No. with MDR A. baumannii Sensitivity Surveillance sites Nostrils 22 4 18 Pharynx 22 5 23 Skin 22 3 13.5 Rectum 21 3 14 Clinical Sites Wounds (only wounds with discharge) Endotracheal Aspirates 9 2 22 7 2 29 Marchaim D. J Clin Micro 2007; 45: 1551-1555

Duration of Carriage 140 samples obtained from 30 patients with a remote (> 6 months) history of Acinetobacter baumannii 5 (17%) has at least one positive surveillance culture Length of time from the last clinical isolate ranged from 8-42 months Marchaim D. J Clin Micro 2007; 45: 1551-1555

Recommendation for Discontinuing Isolation Do not discontinue for remainder of hospitalization Patients with a known history are isolated upon readmission Isolation is discontinued when: At least 6 months since last positive culture 3 negative surveillance cultures (collected from skin and throat) Surveillance cultures must be collected with patient off antibiotics and at least 1 week apart

Immunocompromised Patients Prolonged shedding can occur VZV skin/oral? Adenovirus respiratory, urine Cryptosporidium (duration diarrhea) stool Parainfluenza - respiratory

Conclusions Discontinuing isolation is a judgment call based upon published guidelines and research, and assessment of patient population Infection Control Professionals must weigh the negative consequences of isolation with the potential risk of disease transmission to susceptible patients Our first priority is always to protect other patients and employees

Thank You! Enjoy Denver!